6MD Stock Overview

Develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. More details

6MD fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	2/6
Past Performance	5/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 7.3% below our estimate of its fair value

Earnings are forecast to grow 13.64% per year

Earnings grew by 53.9% over the past year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Medacta Group SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medacta Group
Historical stock prices
Current Share Price	CHF 147.00
52 Week High	CHF 154.00
52 Week Low	CHF 143.40
Beta	1.14
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	68.52%

Recent updates

Shareholder Returns

	6MD	DE Medical Equipment	DE Market
7D	-3.2%	-5.6%	-0.9%
1Y	n/a	-14.8%	14.1%

Return vs Industry: Insufficient data to determine how 6MD performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 6MD performed against the German Market.

Price Volatility

Is 6MD's price volatile compared to industry and market?
6MD volatility
6MD Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.7%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.7%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: 6MD's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 6MD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1958	1,907	Francesco Siccardi	www.medacta.com

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Medacta Group SA Fundamentals Summary

How do Medacta Group's earnings and revenue compare to its market cap?
6MD fundamental statistics
Market cap	€2.90b
Earnings (TTM)	€72.89m
Revenue (TTM)	€590.58m

39.7x

P/E Ratio

4.9x

P/S Ratio

Is 6MD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6MD income statement (TTM)
Revenue	€590.58m
Cost of Revenue	€191.14m
Gross Profit	€399.44m
Other Expenses	€326.55m
Earnings	€72.89m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Sep 08, 2025

Earnings per share (EPS)	3.66
Gross Margin	67.64%
Net Profit Margin	12.34%
Debt/Equity Ratio	51.1%

How did 6MD perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

20%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/25 16:01
End of Day Share Price	2025/05/23 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medacta Group SA is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Samuel England	Berenberg
Maria Vara Fernández	Bryan Garnier & Co
Christoph Gretler	Credit Suisse

Medacta Group DB:6MD Stock Report